RBC Capital initiated coverage of DexCom with an Outperform rating and $165 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on DXCM:
- Early notable gainers among liquid option names on March 6th
- DexCom’s (NASDAQ:DXCM) Stelo Becomes First Glucose Monitor Cleared for OTC Use
- DexCom announces FDA clears Stelo biosensor
- DexCom announces new CGM data, direct to Apple Watch functionality in Q2
- DexCom call volume above normal and directionally bullish